Perfusio
GREENVILLE, North Carolina, United States · Healthcare
Perfusio is a medical device company in Greenville, North Carolina. Perfusio’s first form factor, called Certes™, is FDA-cleared through the 510(k) process as a Class II device, to address the problem that humans cannot see blood flow distribution in tissues in visible light. Certes™ utilizes multiple wavelength illumination and AI-enhanced analytics based on laser speckle contrast imaging to disp
Key facts
- Headquarters
- GREENVILLE, North Carolina, United States
- Employees
- Unknown
- Industries
- Healthcare
- Status
- Private
- Website
- perfusio.com
- Company page
Recent activity at Perfusio
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Perfusio funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2024 | Seed | $2.2M |
| Jul 2022 | Seed | $1.6M |
| Aug 2020 | Seed | $2.0M |
| Mar 2019 | Seed | $869K |
| Sep 2017 | Seed | $3.5M |
Leadership
- MONTE TUCKER, Executive Officer, Director
- THOMAS FERGUSON, Director
- CHENG CHEN, Director
- WILLIAM HODGES, Director
- STEVE TAYLOR, Director
- RICHARD BALOT, Director
- KENICHI MATSUMURA, Director
- GEORGE MCGINN, Director
- MIKE SNOW, Director
- DAVID LAVANCE, Director
Verified email and direct lines for Perfusio’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Perfusio in the news
- Perfusion Abnormalities on 24-Hour Perfusion Imaging in Patients With Complete Endovascular Reperfusion - American Heart Association Journals (Aug 15, 2024)
- Hemadyne: accordion-inspired perfusion for microphysiological systems - Nature (May 25, 2026)
- Quantitative Perfusion Imaging with Total-Body PET - Journal of Nuclear Medicine (Nov 01, 2023)
- Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection - The New England Journal of Medicine (Feb 12, 2024)
- Interpretation of SPECT/CT Myocardial Perfusion Images: Common Artifacts and Quality Control Techniques - RSNA Journals (Mar 23, 2018)
- A clinically deployed dual-compartment biochemical monitoring platform for human liver perfusion - Nature (Jul 14, 2026)
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging - The New England Journal of Medicine (Jan 24, 2018)
- Review of Perfusion Imaging in Acute Ischemic Stroke: - American Heart Association Journals (Feb 03, 2020)
Companies similar to Perfusio
- Opyn Health · Healthcare
- Metabolon · Healthcare
- Monogram Health · Healthcare
- Vivani Medical, Inc. · Healthcare
- Catalent Pharma Solutions · Healthcare
About Perfusio: questions and answers
What does Perfusio do?
Perfusio is a medical device company in Greenville, North Carolina. Perfusio’s first form factor, called Certes™, is FDA-cleared through the 510(k) process as a Class II device, to address the problem that humans cannot see blood flow distribution in tissues in visible light. Certes™ utilizes multiple wavelength illumination and AI-enhanced analytics based on laser speckle contrast imaging to disp
Where is Perfusio headquartered?
Perfusio is headquartered in GREENVILLE, North Carolina, United States.
Has Perfusio raised funding?
Yes. Fundz has recorded 5 funding events for Perfusio. The most recent, Seed of $2.2M, was in Nov 2024.
What is the latest news on Perfusio?
On Nov 13, 2024, PERFUSIO
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy